Canopy Growth Corporation
Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a diversified cannabis company. The Company, through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Canopy Growth's stock, expecting it to rise to $7.88.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CGC
Canada Domestic Champions Explained | Trade War Shield
Recent U.S. tariffs have caused a contraction in Canada's export-driven economy, creating a unique investment opportunity. This theme focuses on Canadian companies that serve the domestic market and are insulated from international trade disputes.
Published: August 30, 2025
Explore BasketVice Arbitrage
Get exposure to companies leading the transformation of once-prohibited activities into booming legal industries. These carefully selected stocks represent market leaders capitalizing on shifting regulations in sports betting, cannabis, and more, unlocking tremendous growth potential.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Market recovery watch
Watch for signs of revenue stabilisation and margin improvement as indicators of recovery, though performance can vary and is not guaranteed.
Product innovation
New formats and branded products can drive consumer demand, but success depends on execution, distribution and changing consumer tastes.
Regulatory drivers
Shifts in regulation, especially in the US, could materially change the opportunity set, but regulatory outcomes are uncertain and carry risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
